睿智医药：关于持股5%以上股东减持股份的预披露公告

Group 1 - The core point of the article is that two major shareholders of Ruizhi Pharmaceutical plan to reduce their holdings in the company by a total of 14,938,919 shares, which represents 3% of the total share capital [2] - Shareholder Liang Yufeng, who holds 26,185,660 shares (5.26% of total shares), intends to sell up to 14,938,919 shares within three months after a 15 trading day period from the announcement date [2] - Shareholder Yu Xianwen, who holds 25,000,000 shares (5.02% of total shares), also plans to reduce his holdings by the same amount of 14,938,919 shares under similar conditions [2]